CodeMap® Compliance Briefing: May 5, 2017
Editor's Welcome: CLIA waived nucleic acid based assays are now available for several commonly performed infectious agents including Streptococcus A, Influenza A and B, and Respiratory Syncytial Virus (RSV). These tests can be performed in point of care (POC) settings and provide highly accurate results for patients while they are seeing their physicians. Such results can be particularly useful when treating pediatric patients and can aid in determining if antibiotic treatment is warranted. Today, we will discuss how providers should code and report these procedures, and the resultant payment from Medicare. As always, please forward your questions, comments, and suggestions to us via email.
Sorry, the full document you are trying to access requires an active subscription.
Please login to the left.